|
|||||
|
|
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy |
|
| Authors: | Bangalore Sripal,Messerli Franz H,Cohen Jerome D,Bacher Peter H,Sleight Peter,Mancia Giuseppe,Kowey Peter,Zhou Qian,Champion Annette,Pepine Carl J INVEST Investigators |
| Affiliation: | a Division of Cardiovascular Medicine, St. Luke's-Roosevelt Hospital Center, New York, NY b Department of Medicine, Saint Louis University, St Louis, MO c Abbott Laboratories, Abbott Park, Chicago, IL d Department of Medicine, Lankenau Hospital, Wynnewood, PA e Department of Medicine, Universita Degli Studi, Monza, Italy f Main Line Health Heart Center, Wynnewood, Philadelphia, PA g Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |